Invention Grant
- Patent Title: Engineered chimeric fusion protein compositions and methods of use thereof
-
Application No.: US18156319Application Date: 2023-01-18
-
Publication No.: US11944680B2Publication Date: 2024-04-02
- Inventor: Daniel Getts , Yuxiao Wang , Bruce McCreedy, Jr.
- Applicant: Myeloid Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: MYELOID THERAPEUTICS, INC.
- Current Assignee: MYELOID THERAPEUTICS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Wilson Sonsini Goodrich & Rosati
- The original application number of the division: US17590504 2022.02.01
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K9/00 ; A61K9/127 ; A61K9/51 ; A61K38/17 ; A61K48/00 ; A61P35/00
Abstract:
Compositions and methods for making and using engineered cells, such as, engineered myeloid cells that express a chimeric fusion protein that has a binding domain capable to binding surface molecules on target cells such as diseased cells.
Public/Granted literature
- US20230277659A1 ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF Public/Granted day:2023-09-07
Information query
